Sumitomo Dainippon Pharma Co's market cap is currently $2.03B. The company's EPS TTM is $-3.016; its P/E ratio is ―; Sumitomo Dainippon Pharma Co is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 314.56B	¥ 555.54B	¥ 560.03B	¥ 515.95B	¥ 482.73B
Gross Profit	¥ 187.98B	¥ 376.63B	¥ 402.91B	¥ 378.18B	¥ 353.06B
Operating Income	¥ -354.19B	¥ -76.98B	¥ 60.23B	¥ 71.22B	¥ 83.24B
EBITDA	¥ -281.07B	¥ -3.50B	¥ 124.36B	¥ 103.11B	¥ 100.29B
Net Income	¥ -314.97B	¥ -74.51B	¥ 56.41B	¥ 56.22B	¥ 40.75B
Balance Sheet
Cash & Short-Term Investments	¥ 29.05B	¥ 163.65B	¥ 238.58B	¥ 223.18B	¥ 130.43B
Total Assets	¥ 907.51B	¥ 1.13T	¥ 1.31T	¥ 1.31T	¥ 1.25T
Total Debt	¥ 418.88B	¥ 334.72B	¥ 269.05B	¥ 273.82B	¥ 297.98B
Net Debt	¥ 389.84B	¥ 191.24B	¥ 66.06B	¥ 80.12B	¥ 196.27B
Total Liabilities	¥ 751.37B	¥ 727.96B	¥ 634.44B	¥ 659.95B	¥ 620.77B
Stockholders' Equity	¥ 156.06B	¥ 406.75B	¥ 607.89B	¥ 580.57B	¥ 529.49B
Cash Flow
Free Cash Flow	¥ -257.62B	¥ -805.00M	¥ 17.75B	¥ 124.80B	¥ 32.78B
Operating Cash Flow	¥ -241.89B	¥ 11.94B	¥ 31.24B	¥ 135.60B	¥ 46.13B
Investing Cash Flow	¥ 33.04B	¥ 52.42B	¥ -18.28B	¥ 8.88B	¥ -312.68B
Financing Cash Flow	¥ 77.85B	¥ -146.82B	¥ -21.43B	¥ -57.22B	¥ 231.08B

Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History

Income Statement >

Sumitomo Dainippon Pharma Co Debt to Assets

Balance Sheet >

Sumitomo Dainippon Pharma Co Cash Flow

Cash Flow >

Sumitomo Dainippon Pharma Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing